Brief: Spectrum Pharmaceuticals Reports Q1 2023 Financial Results And Corporate Update
09/05/2023 12:25
May 9 (Reuters) - Spectrum Pharmaceuticals Inc SPPI.O :
* SPECTRUM PHARMACEUTICALS REPORTS FIRST QUARTER 2023
FINANCIAL
RESULTS AND CORPORATE UPDATE
* SPECTRUM PHARMACEUTICALS INC - Q1 2023 NET SALES OF $15.6
MILLION, AN INCREASE OF 54% COMPARED TO Q4 2022
* SPECTRUM PHARMACEUTICALS INC Q1 LOSS PER SHARE FROM
CONTINUING
OPERATIONS $0.02
Source text for Eikon: ID:nBw4GBXS1a
Further company coverage: SPPI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Spectrum Pharmaceuticals
See all newsBrief: Assertio Holdings Announces Favorable Vote On Proposed Acquisition Of Spectrum Pharmaceuticals
Brief: Independent Proxy Advisory Firms ISS And Glass Lewis Recommend Spectrum Pharmaceuticals Stockholders Vote “For” Proposed Deal With Assertio Holdings, Inc.
Brief: Spectrum Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement
U.S. RESEARCH ROUNDUP-CTI Biopharma, Park National, Playags
Spectrum Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary